(Q37697813)

22 August 2017

1 reference

title

Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing (English)

1 reference

22 August 2017

1 reference

1 reference

Julie Chao

1

1 reference

22 August 2017

Bo Shen

2

1 reference

22 August 2017

Lin Gao

3

1 reference

22 August 2017

Chun-Fang Xia

4

1 reference

22 August 2017

Grant Bledsoe

5

1 reference

22 August 2017

Lee Chao

6

1 reference

22 August 2017

language of work or name

1 reference

1 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

391

1 reference

22 August 2017

4

1 reference

22 August 2017

345-355

1 reference

Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis

22 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kallikrein and kinin receptor expression in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kallikrein activates bradykinin B2 receptors in absence of kininogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Role of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

The emerging roles of human tissue kallikreins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kinins in pain and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Isozymes of rat urinary kallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kallikrein-kinin in stroke, cardiovascular and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Experimental therapy with tissue kallikrein against cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kallikrein-induced uterine contraction independent of kinin formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Tissue kallikrein inhibitors in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kallistatin is a potent new vasodilator

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Tissue kallikrein-binding protein reduces blood pressure in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

The human kallikrein gene family: a diversity of expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Thrombin signalling and protease-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kinin receptors in pain and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Tissue kallikrein KLK1 is expressed de novo in endothelial cells and mediates relaxation of human umbilical veins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Targeting kinin B(1) receptor for therapeutic neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Akt/protein kinase B and endothelial nitric oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Tissue kallikrein actions at the rabbit natural or recombinant kinin B2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Neutrophils and the kallikrein-kinin system in proteinase-activated receptor 4-mediated inflammation in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Regulation of angiogenesis by glycogen synthase kinase-3beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kallistatin is a new inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

The kallikrein-kinin system: current and future pharmacological targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Adenovirus-mediated kallikrein gene transfer inhibits neointima formation via increased production of nitric oxide in rat artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Protease activated receptors: theme and variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Proteinase-activated receptors, targets for kallikrein signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Urinary enzymes, nephrotoxicity and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Bradykinin receptors and their antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

CP-0597, a selective bradykinin B2 receptor antagonist, inhibits brain injury in a rat model of reversible middle cerebral artery occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

The radioimmunoassay of human urinary kallikrein and comparisons with kallikrein activity measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Tissue kallikrein is synthesized and secreted by human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

The new human tissue kallikrein gene family: structure, function, and association to disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.042

21 January 2018

Identifiers

DOI

10.1515/BC.2010.042

1 reference

22 August 2017

1 reference